Erudio Healtherudio.com
Sponsor
BeOne Medicines (formerly BeiGene) trials: what clinicians said in public
An HCP commentary report on 1 clinical trial sponsored by BeOne Medicines (formerly BeiGene): BGB-11417-101. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 10 more trials with public commentary and no report yet.
Listed by lead sponsor as registered on ClinicalTrials.gov (BeOne Medicines; BeiGene). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| BGB-11417-101 NCT04277637 · BeOne Medicines | mature B-cell malignancies | Phase 1 | 133 | 27 | Focused | Nov 20, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| RATIONALE-315 NCT04379635 · BeiGene DeepView → | resectable stage II–IIIA non-small cell lung cancer | Phase 3 | Deep | View | |||
| ROSEWOOD NCT03332017 · BeiGene DeepView → | relapsed or refractory follicular lymphoma | Phase 2 | Deep | View | |||
| MANGROVE NCT04002297 · BeOne Medicines DeepView → | transplant-ineligible, untreated mantle cell lymphoma | Phase 3 | Deep | View | |||
| CaDAnCe-101 NCT05006716 · BeOne Medicines DeepView → | B-cell malignancies | Phase 1/Phase 2 | Deep | View | |||
| RATIONALE-301 NCT03412773 · BeiGene DeepView → | first-line unresectable hepatocellular carcinoma | Phase 3 | Deep | View | |||
| CELESTIAL-RRMCL NCT06742996 · BeOne Medicines FocusedView → | relapsed/refractory mantle cell lymphoma | Phase 3 | Focused | View | |||
| SAFFRON-301 NCT04921358 · BeiGene FocusedView → | locally advanced or metastatic non-small cell lung cancer | Phase 3 | Focused | View | |||
| AdvanTIG-302 NCT04746924 · BeiGene FocusedView → | untreated PD-L1-selected locally advanced, unresectable or metastatic NSCLC | Phase 3 | Focused | View | |||
| NCT06427941 NCT06427941 · BeOne Medicines FocusedView → | advanced or metastatic solid tumors | Phase 1/Phase 2 | Focused | View | |||
| GroundBBreaker 301 NCT07836530 · BeOne Medicines FocusedView → | Not given | Phase 3 | Focused | View | |||